People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
Kiyohiko Hatake, M.D.,Ph.D. Gene Polymorphism Analysis Group Leader: Yoshio Miki, M.D.,Ph.D. Gene Expression Analysis Group Leader: Akihiro Tomida, Ph.D.
Head and Neck Oncology: Kazuyoshi Kawabata: more: Orthopedic Oncology: Seichi Matsumoto : more: Genitourinary Oncology: Iwao Fukui: more: Hematology Oncology: Kiyohiko Hatake
Kiyohiko Hatake (Cancer Chemotherapy Ctr) Yoshikazu Sugimoto (Keio Univ.) Takao Yamori (Cancer Chemotherapy Ctr) Secretary. Hiroyuki Seimiya (Cancer Chemotherapy Ctr)
Next Generation Molecular Targeted Agents for Breast Cancer: Focus on EGFR and VEGFR Pathways: 132-149: Kiyohiko Hatake, Nahomi Tokudome and Yoshinori Ito
Yuko MATSUMOTO, Masaki MORI, Tetsuya OHTSUKI, Kazuo MUROI, Kiyohiko HATAKE, Norio KOMATSU and Keiya OZAWA: Release Date: 2009/07/28 ...
... of Australia), Prof. Tetsuo Taguchi, honorary president of ACOS, Prof. Nagahiro Saijo, president of JSMO (the Japanese Society of Medical Oncology), Prof. Kiyohiko Hatake ...
Kiyohiko Hatake, M.D.,Ph.D. Gene Polymorphism Analysis Group Leader: Yoshio Miki, M.D.,Ph.D. Gene Expression Analysis Group Leader: Akihiro Tomida, Ph.D.
Kiyohiko Hatake (Cancer Chemotherapy Ctr) Yoshikazu Sugimoto (Keio Univ.) Takao Yamori (Cancer Chemotherapy Ctr) Secretary. Hiroyuki Seimiya (Cancer Chemotherapy Ctr)
Linkedin